OptiNose Cash Flow-to-Debt Ratio
OptiNose cash flow-to-debt ratio. OptiNose (OPTN) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2025, meaning its operating cash flow of $1.67 Million could theoretically repay 0% of its total liabilities ($176.22 Million) in one year. Check OPTN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of OptiNose (2015–2024)
Cash flow-to-debt ratio of OptiNose from 2015 to 2024. Historical debt coverage capacity for OptiNose across 10 annual periods. Check how aggressively does OptiNose reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
OptiNose Cash Flow-to-Debt Ratio by Year (2015–2024)
OptiNose cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for OptiNose. For the full cash flow conversion analysis, see cash efficiency ratio of OptiNose.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.27x | $-44.89 Million | $169.15 Million | ▼ -151.2% |
| 2023 | -0.11x | $-20.53 Million | $194.34 Million | ▲ +68.6% |
| 2022 | -0.34x | $-67.65 Million | $200.85 Million | ▲ +17.8% |
| 2021 | -0.41x | $-76.94 Million | $187.84 Million | ▲ +13.5% |
| 2020 | -0.47x | $-86.21 Million | $182.03 Million | ▲ +42.1% |
| 2019 | -0.82x | $-90.81 Million | $111.07 Million | ▲ +12.4% |
| 2018 | -0.93x | $-91.82 Million | $98.38 Million | ▼ -126.8% |
| 2017 | -0.41x | $-35.65 Million | $86.64 Million | ▼ -186.0% |
| 2016 | 0.48x | $21.72 Million | $45.39 Million | ▲ +171.9% |
| 2015 | -0.67x | $-28.71 Million | $43.16 Million | — |